NCT02348905View on ClinicalTrials.gov

ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

January 31, 2016

Conditions
SarcoidosisCutaneous Sarcoidosis
Interventions
DRUG

ACTHAR Gel 40 units twice weekly

ACTHAR Gel (adrenocorticotropic hormone) 40 units twice weekly between Baseline and week 12.

DRUG

ACTHAR Gel 80 units twice weekly.

ACTHAR Gel (adrenocorticotropic hormone) 80 units twice weekly between Baseline and week 12.

Trial Locations (1)

12208

Albany Medical College, Albany

Sponsors
All Listed Sponsors
lead

Albany Medical College

OTHER